3 | BOL 303259-XIBA
01/2018
-
06/2015 |
3 | Latanoprost (Xalatan)FDA Link
07/2016
-
04/2004 |
3 | latrunculin BIBA
09/2014
-
01/2004 |
3 | 1- (5- Isoquinolinesulfonyl)- 2- Methylpiperazine (H 7)IBA
12/2010
-
08/2004 |
2 | AntioxidantsIBA
01/2017
-
10/2014 |
2 | Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
12/2010
-
06/2007 |
2 | Calmodulin-Binding Proteins (Caldesmon)IBA
06/2006
-
06/2006 |
2 | SteroidsIBA
06/2006
-
01/2002 |
2 | Mitomycin (Mitomycin-C)FDA LinkGeneric
08/2002
-
07/2002 |
1 | Fluocinolone Acetonide (Capex)FDA LinkGeneric
01/2019 |
1 | Timolol (Blocadren)FDA LinkGeneric
01/2018 |
1 | Ophthalmic Solutions (Eye Drops)IBA
03/2017 |
1 | Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 |
1 | Ranibizumab (Lucentis)FDA Link
01/2017 |
1 | Bevacizumab (Avastin)FDA Link
01/2017 |
1 | Oxidants (Oxidizing Agents)IBA
01/2017 |
1 | afliberceptIBA
01/2017 |
1 | Oxygen (Dioxygen)IBA
01/2017 |
1 | Adenosine Triphosphate (ATP)IBA
05/2015 |
1 | CD39 antigenIBA
05/2015 |
1 | MacrolidesIBA
09/2014 |
1 | cresyl violetIBA
08/2014 |
1 | DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
08/2014 |
1 | Benzalkonium Compounds (Benzalkonium Chloride)FDA LinkGeneric
03/2014 |
1 | Nitric Oxide (Nitrogen Monoxide)FDA Link
07/2013 |
1 | Memantine (Namenda)FDA Link
04/2012 |
1 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
01/2011 |
1 | ActomyosinIBA
12/2010 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
03/2010 |
1 | AnecortaveIBA
03/2010 |
1 | alagebriumIBA
12/2009 |
1 | NADPH Dehydrogenase (Dehydrogenase, NADP)IBA
12/2009 |
1 | Calbindin 2IBA
12/2009 |
1 | Synthetic Prostaglandins (Prostaglandin Analogues)IBA
11/2008 |
1 | KetamineFDA LinkGeneric
11/2008 |
1 | OligonucleotidesIBA
09/2008 |
1 | ProstaglandinsIBA
01/2008 |
1 | Cholinergic Agents (Cholinergics)IBA
01/2008 |
1 | EphrinsIBA
09/2007 |
1 | Cholinergic AgonistsIBA
06/2007 |
1 | Pilocarpine (Ocusert)FDA LinkGeneric
06/2007 |
1 | Phenylephrine (Neo-Synephrine)FDA LinkGeneric
06/2007 |
1 | AndrogensIBA
06/2006 |
1 | Androgen Receptors (Androgen Receptor)IBA
06/2006 |
1 | Indicators and Reagents (Reagents)IBA
03/2006 |
1 | Proteins (Proteins, Gene)FDA Link
07/2005 |
1 | Peroxynitrous Acid (Peroxynitrite)IBA
01/2005 |
1 | 3-nitrotyrosineIBA
01/2005 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2005 |
1 | Amino AcidsFDA Link
01/2005 |
1 | Retinaldehyde (Retinal)IBA
07/2004 |
1 | Melanins (Melanin)IBA
04/2004 |
1 | 3R,5S)-2-((1E)-3,3-difluoro-4-phenoxy - 1- butenyl)- 3,5- dihydroxycyclopentyl)- 5- heptenoic acid (5Z)-7-((1R,2RIBA
04/2004 |
1 | tafluprostIBA
04/2004 |
1 | PhXa 85IBA
04/2004 |
1 | prostaglandin F2alpha receptorIBA
04/2004 |
1 | Matrix Metalloproteinase 14 (MT1-MMP)IBA
03/2003 |
1 | Matrix Metalloproteinases (MMPs)IBA
03/2003 |
1 | 1,7- dioxa- 2,6- diaza- 4,7a- dithia- 3H,5H- benzo(cd)pentaleneIBA
01/2002 |
1 | Fibronectins (Fibronectin)IBA
01/2002 |